H Sinzinger

1.1k total citations
144 papers, 783 citations indexed

About

H Sinzinger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, H Sinzinger has authored 144 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 28 papers in Cardiology and Cardiovascular Medicine and 24 papers in Pharmacology. Recurrent topics in H Sinzinger's work include Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Inflammatory mediators and NSAID effects (14 papers) and Lipoproteins and Cardiovascular Health (8 papers). H Sinzinger is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Inflammatory mediators and NSAID effects (14 papers) and Lipoproteins and Cardiovascular Health (8 papers). H Sinzinger collaborates with scholars based in Austria, Germany and Russia. H Sinzinger's co-authors include K Silberbauer, J Kaliman, P Fitscha, A. Oguogho, H Kritz, C Leithner, Irene Virgolini, W Feigl, M. Winter and W. Firbas and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Thrombosis and Haemostasis.

In The Last Decade

H Sinzinger

138 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Sinzinger Austria 14 201 189 127 113 112 144 783
J Kaliman Austria 13 115 0.6× 213 1.1× 66 0.5× 88 0.8× 66 0.6× 78 513
P Fitscha Austria 14 169 0.8× 295 1.6× 78 0.6× 136 1.2× 68 0.6× 100 643
J.A. Jakubowski United States 17 230 1.1× 410 2.2× 142 1.1× 103 0.9× 178 1.6× 32 1.3k
Chung‐hsin Ts'ao United States 19 231 1.1× 252 1.3× 269 2.1× 68 0.6× 224 2.0× 52 1.1k
J. Zahavi United Kingdom 19 333 1.7× 471 2.5× 214 1.7× 117 1.0× 68 0.6× 37 1.1k
Katsuhiko Yonemura Japan 18 144 0.7× 102 0.5× 119 0.9× 37 0.3× 306 2.7× 49 1.1k
Ramón Montes Spain 21 122 0.6× 285 1.5× 102 0.8× 64 0.6× 178 1.6× 56 1.1k
William A. Wilmer United States 15 126 0.6× 181 1.0× 126 1.0× 109 1.0× 365 3.3× 20 1.2k
Susumu Yukawa Japan 16 164 0.8× 91 0.5× 110 0.9× 66 0.6× 81 0.7× 61 722
N Islam United States 13 162 0.8× 339 1.8× 102 0.8× 138 1.2× 219 2.0× 18 1.3k

Countries citing papers authored by H Sinzinger

Since Specialization
Citations

This map shows the geographic impact of H Sinzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Sinzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Sinzinger more than expected).

Fields of papers citing papers by H Sinzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Sinzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Sinzinger. The network helps show where H Sinzinger may publish in the future.

Co-authorship network of co-authors of H Sinzinger

This figure shows the co-authorship network connecting the top 25 collaborators of H Sinzinger. A scholar is included among the top collaborators of H Sinzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Sinzinger. H Sinzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berent, Robert, et al.. (2010). Acute myocardial infarction with ST segment elevation in inferior and anterior leads: right ventricular infarction. BMJ Case Reports. 2010. bcr0320091700–bcr0320091700. 2 indexed citations
2.
Rodrigues, Michele Ângela, et al.. (2001). Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines. Nuclear Medicine Communications. 22(6). 645–650. 5 indexed citations
3.
Lupattelli, Graziana, Barbara Palumbo, & H Sinzinger. (2001). Statin induced myopathy does not show up in MIBI scintigraphy. Nuclear Medicine Communications. 22(5). 575–578. 12 indexed citations
4.
Sinzinger, H, et al.. (2001). In vitro adsorption of 99Tcm-MIBI, 99Tcm-tetrofosmin, 99Tcm-furifosmin and 99TcmO4??? onto tubes. Nuclear Medicine Communications. 22(1). 105–110. 4 indexed citations
5.
Sinzinger, H, et al.. (1999). Hyperhomocysteinämie und Atherosklerose. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(7). 364–368. 1 indexed citations
6.
Kritz, H, C. Zielinski, & H Sinzinger. (1996). Low cholesterol and cancer.. Journal of Clinical Oncology. 14(11). 3043–3048. 16 indexed citations
7.
Neumann, Irmgard, W. Rogatti, Irene Virgolini, W. Firbas, & H Sinzinger. (1992). Prostaglandin (PG) E1 and 13,14-Dihydro(DH)PGE1 are Diminishing Radiation-Induced Arterial Damage. Birkhäuser Basel eBooks. 37. 58–65. 1 indexed citations
8.
Sinzinger, H & Irene Virgolini. (1989). [Do passive smokers have an increased risk of thrombosis?].. PubMed. 101(20). 694–8. 7 indexed citations
9.
Virgolini, Irene, Martin Hermann, & H Sinzinger. (1989). Decrease of the prostaglandin I2 binding capacity in thyroids from patients with Graves' disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 37(2). 121–128. 3 indexed citations
10.
Fitscha, P, J Kaliman, John O’Grady, & H Sinzinger. (1988). In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins.. PubMed. 115(4). 443–6. 4 indexed citations
11.
Matĕjka, M, et al.. (1988). Indium 111-A-bleomycin—A new tracer for imaging orofacial neoplasms. Journal of Oral and Maxillofacial Surgery. 46(9). 742–745. 2 indexed citations
12.
Kaliman, J, P Fitscha, Harald Barth, & H Sinzinger. (1987). Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue.. PubMed. 242. 469–77. 2 indexed citations
13.
Ludwig, Heinz, Agostino Cortelezzi, E Polli, et al.. (1985). Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative Diseases. Oncology. 42(1). 19–25. 16 indexed citations
14.
Sinzinger, H, et al.. (1985). [Deficiencies of the prostaglandin system: III. A partial thromboxane synthetase defect].. PubMed. 97(13). 561–5. 1 indexed citations
15.
Sinzinger, H, et al.. (1985). In-vitro effects of buflomedil on parameters regulating hemostatic balance via the prostaglandin-system.. PubMed. 14(1). 71–3. 1 indexed citations
16.
Schernthaner, G., et al.. (1982). Activation of platelet in vivo function and plasma levels of catecholamines and growth hormone during bicycle exercise in juvenile diabetes and healthy individuals.. PubMed. 11. 69–83. 3 indexed citations
17.
Sinzinger, H, C Leithner, & Martin Schwarz. (1981). Monitoring of human kidney transplants using quantification of autologous indium 111 labeled oxine platelet label deposition beneficial effect of prostaglandin i 2 treatment in acute and chronic rejection. Thrombosis and Haemostasis. 46(1). 263. 1 indexed citations
18.
Schernthaner, G., et al.. (1976). [Study of age and sex dependance in renal clearances with radioisotopes (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(3). 139–45. 2 indexed citations
19.
Dadak, Ch., H Sinzinger, & W Feigl. (1976). [A combined calcium--fat staining with determination of vessel wall permeability].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 94(1). 155–60. 3 indexed citations
20.
Mohamed, Sara, H Sinzinger, C Scheiner, & H. Pietschmann. (1976). [Fetal haemoglobin levels in acquired and congenital haematological diseases and malignant tumours in adults (author's transl)].. PubMed. 88(15). 485–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026